# FDA Inspection 1062692 - Cardinal Health 418, Inc. - July 11, 2018

Source: https://www.keypedia.com/records/fda_inspections/cardinal-health-418-inc/8eec3266-69c3-4c68-9b12-25800621402a
Source feed: FDA_Inspections

> FDA Inspection 1062692 for Cardinal Health 418, Inc. on July 11, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062692
- Company Name: Cardinal Health 418, Inc.
- Inspection Date: 2018-07-11
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1118976 - 2020-02-21](https://www.keypedia.com/records/fda_inspections/cardinal-health-418-inc/22faefdc-3114-4145-9866-66d5e64315c9)
- [FDA Inspection 883410 - 2014-06-17](https://www.keypedia.com/records/fda_inspections/cardinal-health-418-inc/1ace5a5e-aba1-485d-8eb1-1e026bcda94f)

Company: https://www.keypedia.com/companies/cardinal-health-418-inc/86385c39-f27c-4ce4-bb8d-cda5d4450812

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c